Andrew Joy is a Senior Advisor and Chairman of the Private Equity Investment Committee at Fleming Family & Partners, a leading international wealth management firm. He was a Founding Partner of Cinven, a member of the Executive Committee and a member of the Portfolio Review Committee and remains a Senior Advisor to the firm. He was formerly a Director of Hill Samuel Bank and Managing Director of Hill Samuel Development Capital. He has been Chairman or Director of numerous growing private companies.
Stonehage Fleming Family & Partners is the largest multi-family office in Europe, serving individuals and families seeking fiduciary, asset management and other services. Andrew is a Senior Advisor and Chairman of the Private Equity Investment Committee.
Cinven is a leading private equity firm with some €15bn under management, with offices across Europe, in Hong Kong and in New York. Within its chosen sectors Cinven buys companies capable of strong growth and helps them realise that through management initiatives and international expansion. It has about 200 institutional investors.
The Biotech Growth Trust is a £600m investment trust focusing on biotechnology companies globally, but chiefly in the US. It is the best performing UK investment trust over 3,5 and 10 years to May 2015 as measured by NAV.
